|
|
|
| |
| Management Team |
 |
|
 |
|
|
Elliott
L. Fineman |
| President and CEO |
| Elliott joined Planet in 1998.
Before that he founded and served as Chief Operating Officer, Vice President and Director of Licensing and Intellectual Property of SuperGen, Inc., from January 1991 to August 1995. |
|
|
| |
 |
|
|
James W. Larrick |
|
Vice President and Chief Scientific Officer |
| Dr Larrick has an international reputation in biotechnology [cytokines, therapeutic antibodies, molecular biology, pharmaceutical drug development] having written or co-authored eight books, over 220 papers/chapters and fifteen patents. |
|
|
| |
 |
|
|
Jeffrey S. Price |
| Chairman |
|
As President and CEO of Neurobiological Technologies Inc., Richmond, CA (until May, 1997),
Dr Price raised approximately $30 million, including an IPO in February 1994, and brought four products into phase II clinical trials. |
|
|
| |
|
|
|
 |
|
|
Keith L. Wycoff |
|
Vice President of Research |
| Dr Wycoff has directed
research efforts at Planet Biotechnology since
1996 and has been the Principal Investigator
on most of our grant-funded projects. Grants
he authored have brought in more than $25
million in non-dilutive funds. |
|
|
|
|
 |
|
|
| |
|
|
